Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 14.59
LCAV's Cash to Debt is ranked higher than
88% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 0.28 vs. LCAV: 14.59 )
LCAV' s 10-Year Cash to Debt Range
Min: 0.06   Max: No Debt
Current: 14.59

Equity to Asset 0.47
LCAV's Equity to Asset is ranked higher than
71% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. LCAV: 0.47 )
LCAV' s 10-Year Equity to Asset Range
Min: -0.12   Max: 0.94
Current: 0.47

-0.12
0.94
F-Score: 3
Z-Score: 3.27
M-Score: -2.95
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -9.41
LCAV's Operating margin (%) is ranked lower than
52% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 9.71 vs. LCAV: -9.41 )
LCAV' s 10-Year Operating margin (%) Range
Min: -31.82   Max: 27.66
Current: -9.41

-31.82
27.66
Net-margin (%) -8.39
LCAV's Net-margin (%) is ranked lower than
51% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 4.97 vs. LCAV: -8.39 )
LCAV' s 10-Year Net-margin (%) Range
Min: -44.89   Max: 25.2
Current: -8.39

-44.89
25.2
ROE (%) -43.02
LCAV's ROE (%) is ranked lower than
54% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 9.92 vs. LCAV: -43.02 )
LCAV' s 10-Year ROE (%) Range
Min: -341.67   Max: 34.73
Current: -43.02

-341.67
34.73
ROA (%) -17.39
LCAV's ROA (%) is ranked lower than
55% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 3.98 vs. LCAV: -17.39 )
LCAV' s 10-Year ROA (%) Range
Min: -54.12   Max: 24.72
Current: -17.39

-54.12
24.72
ROC (Joel Greenblatt) (%) -149.69
LCAV's ROC (Joel Greenblatt) (%) is ranked lower than
55% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 17.97 vs. LCAV: -149.69 )
LCAV' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -149.69   Max: 167.28
Current: -149.69

-149.69
167.28
Revenue Growth (%) -8.40
LCAV's Revenue Growth (%) is ranked higher than
52% of the 182 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. LCAV: -8.40 )
LCAV' s 10-Year Revenue Growth (%) Range
Min: -28.7   Max: 34.1
Current: -8.4

-28.7
34.1
EBITDA Growth (%) -43.10
LCAV's EBITDA Growth (%) is ranked lower than
51% of the 164 Companies
in the Global Medical Care industry.

( Industry Median: 7.20 vs. LCAV: -43.10 )
LCAV' s 10-Year EBITDA Growth (%) Range
Min: -100   Max: 158.1
Current: -43.1

-100
158.1
EPS Growth (%) -36.90
LCAV's EPS Growth (%) is ranked higher than
53% of the 145 Companies
in the Global Medical Care industry.

( Industry Median: 9.80 vs. LCAV: -36.90 )
LCAV' s 10-Year EPS Growth (%) Range
Min: -46.9   Max: 44.9
Current: -36.9

-46.9
44.9
» LCAV's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

LCAV Guru Trades in Q1 2013

Jim Simons 679,104 sh (+7.84%)
Julian Robertson Sold Out
Pioneer Investments Sold Out
» More
Q2 2013

LCAV Guru Trades in Q2 2013

Jim Simons 646,404 sh (-4.82%)
» More
Q3 2013

LCAV Guru Trades in Q3 2013

Jim Simons 649,900 sh (+0.54%)
» More
Q4 2013

LCAV Guru Trades in Q4 2013

Jim Simons 634,800 sh (-2.32%)
» More
» Details

Insider Trades

Latest Guru Trades with LCAV

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Julian Robertson 2013-03-31 Sold Out 0.62%$2.8 - $3.55 $ 5.471%0
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 5.50
LCAV's P/B is ranked lower than
66% of the 222 Companies
in the Global Medical Care industry.

( Industry Median: 2.29 vs. LCAV: 5.50 )
LCAV' s 10-Year P/B Range
Min: 0.48   Max: 8.86
Current: 5.5

0.48
8.86
P/S 1.10
LCAV's P/S is ranked higher than
61% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.37 vs. LCAV: 1.10 )
LCAV' s 10-Year P/S Range
Min: 0.19   Max: 6.73
Current: 1.1

0.19
6.73
EV-to-EBIT 10.50
LCAV's EV-to-EBIT is ranked higher than
86% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 17.82 vs. LCAV: 10.50 )
LCAV' s 10-Year EV-to-EBIT Range
Min: 0.6   Max: 60.8
Current: 10.5

0.6
60.8

Valuation & Return

vs
industry
vs
history
Price/Net Cash 21.60
LCAV's Price/Net Cash is ranked higher than
65% of the 26 Companies
in the Global Medical Care industry.

( Industry Median: 51.70 vs. LCAV: 21.60 )
LCAV' s 10-Year Price/Net Cash Range
Min: 2.41   Max: 82.14
Current: 21.6

2.41
82.14
Price/Net Current Asset Value 13.20
LCAV's Price/Net Current Asset Value is ranked higher than
65% of the 40 Companies
in the Global Medical Care industry.

( Industry Median: 18.60 vs. LCAV: 13.20 )
LCAV' s 10-Year Price/Net Current Asset Value Range
Min: 2.3   Max: 25.64
Current: 13.2

2.3
25.64
Price/Tangible Book 5.50
LCAV's Price/Tangible Book is ranked lower than
62% of the 142 Companies
in the Global Medical Care industry.

( Industry Median: 3.90 vs. LCAV: 5.50 )
LCAV' s 10-Year Price/Tangible Book Range
Min: 0.79   Max: 577.78
Current: 5.5

0.79
577.78
Price/Median PS Value 1.00
LCAV's Price/Median PS Value is ranked higher than
83% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 1.10 vs. LCAV: 1.00 )
LCAV' s 10-Year Price/Median PS Value Range
Min: 0.32   Max: 9.17
Current: 1

0.32
9.17
Earnings Yield (Greenblatt) 9.50
LCAV's Earnings Yield (Greenblatt) is ranked higher than
86% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 5.50 vs. LCAV: 9.50 )
LCAV' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.6   Max: 162.5
Current: 9.5

1.6
162.5
Forward Rate of Return (Yacktman) -2.99
LCAV's Forward Rate of Return (Yacktman) is ranked higher than
56% of the 169 Companies
in the Global Medical Care industry.

( Industry Median: 11.19 vs. LCAV: -2.99 )
LCAV' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -1.7   Max: 84
Current: -2.99

-1.7
84

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:LCV1.Germany
LCA-Vision, Inc., is a provider of fixed-site laser vision correction services at its LasikPlus vision centers. Its vision centers provide the staff, facilities, equipment and support services for performing laser vision correction that employ advanced laser technologies to help correct nearsightedness, farsightedness and astigmatism. Its vision centers are supported by ophthalmologists and credentialed optometrists, as well as other healthcare professionals. The ophthalmologists perform the laser vision correction procedures in its vision centers, and ophthalmologists or optometrists conduct pre-procedure evaluations and post-operative follow-up care in-center. It provides two types of procedures in its vision centers namely LASIK; and PRK and Surface Ablation. It began performing LASIK, in 1996, which continues to account for the majority of the laser vision correction procedures performed in the United States. In LASIK procedures, its surgeon's uses a femtosecond laser to create a thin flap, which remains hinged to the eye. In PRK procedures, the ophthalmologist removes the thin layer of cells covering the outer surface of the cornea (the epithelium) in order to apply the excimer laser pulses directly to the surface of the cornea. Following the PRK procedure, the ophthalmologist places a bandage contact lens on the eye to protect it. Most of its patients currently receive a procedure called laser-assisted in situ keratomileusis ('LASIK'), which it began performing in the United States in 1996. As of December 31, 2012, it operated 54 LasikPlus fixed-site laser vision correction centers generally located in metropolitan markets in the United States, including two vision centers licensed to ophthalmologists who operate using its trademarks. It currently uses two suppliers for its fixed-site excimer lasers: Abbott Medical Optics ('AMO') and Alcon Inc. ('Alcon'). Its business is heavily dependent on advertising, which is subject to regulation by the Federal Trade Commission ('FTC').

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide